1. Home
  2. ITRM vs VTMX Comparison

ITRM vs VTMX Comparison

Compare ITRM & VTMX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ITRM
  • VTMX
  • Stock Information
  • Founded
  • ITRM 2015
  • VTMX 1998
  • Country
  • ITRM Ireland
  • VTMX Mexico
  • Employees
  • ITRM N/A
  • VTMX N/A
  • Industry
  • ITRM Biotechnology: Pharmaceutical Preparations
  • VTMX
  • Sector
  • ITRM Health Care
  • VTMX
  • Exchange
  • ITRM Nasdaq
  • VTMX Nasdaq
  • Market Cap
  • ITRM 35.6M
  • VTMX 2.3B
  • IPO Year
  • ITRM 2018
  • VTMX 2023
  • Fundamental
  • Price
  • ITRM $1.05
  • VTMX $27.62
  • Analyst Decision
  • ITRM Strong Buy
  • VTMX Sell
  • Analyst Count
  • ITRM 2
  • VTMX 2
  • Target Price
  • ITRM $7.00
  • VTMX $27.50
  • AVG Volume (30 Days)
  • ITRM 536.8K
  • VTMX 271.9K
  • Earning Date
  • ITRM 05-13-2025
  • VTMX 04-23-2025
  • Dividend Yield
  • ITRM N/A
  • VTMX 2.54%
  • EPS Growth
  • ITRM N/A
  • VTMX N/A
  • EPS
  • ITRM N/A
  • VTMX 0.13
  • Revenue
  • ITRM N/A
  • VTMX $258,927,122.00
  • Revenue This Year
  • ITRM N/A
  • VTMX $18.81
  • Revenue Next Year
  • ITRM $108.39
  • VTMX $11.83
  • P/E Ratio
  • ITRM N/A
  • VTMX $20.16
  • Revenue Growth
  • ITRM N/A
  • VTMX 15.06
  • 52 Week Low
  • ITRM $0.81
  • VTMX $21.30
  • 52 Week High
  • ITRM $3.02
  • VTMX $37.92
  • Technical
  • Relative Strength Index (RSI)
  • ITRM 44.34
  • VTMX 67.50
  • Support Level
  • ITRM $0.88
  • VTMX $27.05
  • Resistance Level
  • ITRM $1.14
  • VTMX $27.91
  • Average True Range (ATR)
  • ITRM 0.10
  • VTMX 0.85
  • MACD
  • ITRM -0.01
  • VTMX 0.16
  • Stochastic Oscillator
  • ITRM 31.48
  • VTMX 91.52

About ITRM Iterum Therapeutics plc

Iterum Therapeutics PLC is a pharmaceutical company dedicated to maximizing the commercial potential of Orlynvah, an oral-branded penem available in the United States and potentially the first and only oral and intravenous (IV) branded penem available globally. Its product Orlynvah has the potential to be a treatment for complicated urinary tract infections caused by the designated microorganisms, without the presence of known toxicities of some other antibiotics. The company operates in a single business segment, which is the development and commercialization of treatments for drug-resistant bacterial infections.

About VTMX Corporacion Inmobiliaria Vesta S.A.B de C.V. each representing ten (10)

Corporacion Inmobiliaria Vesta SAB de CV is an internally managed real estate company that owns, manages, develops, and leases industrial properties in Mexico. The Company's primary business is the acquisition, development, and management of industrial and distribution center real estate. The company designs and constructs park-to-suit projects across various industries; undertakes build-to-suit projects; and provides site selection, design and engineering, and sale and leaseback services. The primary source of revenue is the rental income received from customers under operating leases. It serves aerospace, automotive, food and beverage, logistics, medical devices, plastics, and other industries.

Share on Social Networks: